BonaDur For Men — Class III drug recall D-0421-2018
Terminated recall by Webrx dba RxPalace.com, reported 2018-02-21, distributed in NY. CGMP Deviations: not manufactured according to current good manufacturing practices.
| Recall number | D-0421-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Webrx dba RxPalace.com, Sarasota, FL, United States |
| Recall initiated | 2018-02-07 |
| Classified | 2018-02-14 |
| Reported by FDA | 2018-02-21 |
| Terminated | 2020-05-19 |
| Distributed | NY |
| Quantity | 1 bottles |
| Reason classes | cgmp |
| NDC | 70582-0999-74 |
| Lot numbers | 17JXIII |
| Expiration dates | 2019-12-31 |
Product
BonaDur For Men (lidocaine) spray, 10 mg per spray, Net Contents .25 fl. oz. (7.4 mL) spray bottles, Manufactured by WebRx Pharmacy Palace, Sarasota, FL 34232; NDC 70582-999-74
Reason for recall
CGMP Deviations: not manufactured according to current good manufacturing practices.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0421-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.